A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor positive breast cancer

PURPOSE: To compare clinical, immunohistochemical and gene expression models of prognosis applicable to formalin-fixed, paraffin-embedded blocks in a large series of estrogen receptor positive breast cancers, from patients uniformly treated with adjuvant tamoxifen. METHODS: qRT-PCR assays for 50 gen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Nielsen, Torsten O., Parker, Joel S, Leung, Samuel, Voduc, David, Ebbert, Mark, Vickery, Tammi, Davies, Sherri R., Snider, Jacqueline, Stijleman, Inge J., Reed, Jerry, Cheang, Maggie C.U., Mardis, Elaine R., Perou, Charles M., Bernard, Philip S., Ellis, Matthew J.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2970720/
https://ncbi.nlm.nih.gov/pubmed/20837693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-1282
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars